Macular degeneration trials in Croatia

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  Where

  Zagreb

  Age

  50 years and over

  People

  561 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07007065 · EU 2024-512298-28-00
• Phase 2/3Taking people
  A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)

  Where

  Osijek, Zagreb

  Age

  18 years and over

  People

  250 worldwide

  Run by

  Eyebiotech Limited

  See details and how to join2025-524894-17-00